Active substance   updacitinib
Holder     AbbVie Belgium sa/nv
Status Running
Indication the treatment of patients with active Crohn's Disease who have no other suitable treatment option and are not eligible to participate in a clinical study for their serious condition
Public documents Approbation
  Information for the patient
  Informed consent
Last update 27/02/2023


Last updated on 23/03/2023